Abeona Therapeutics (ABEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -37,597 | -25,761 | -9,107 | -39,696 | -32,575 |
| Depreciation Amortization | 2,477 | 1,726 | 888 | 4,577 | 3,568 |
| Accounts receivable | -2,021 | -5,539 | -75 | 2,812 | 1,953 |
| Other Working Capital | -2,803 | -5,166 | -2,013 | -5,892 | -1,888 |
| Other Operating Activity | 12,170 | 12,712 | -1,437 | -5,284 | -549 |
| Operating Cash Flow | $-27,774 | $-22,028 | $-11,744 | $-43,483 | $-29,491 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -11,214 | 7,493 | 2,429 | -25,568 | -159 |
| PPE Investments | -107 | -71 | -218 | 1,604 | 1,485 |
| Investing Cash Flow | $-11,321 | $7,422 | $2,211 | $-23,964 | $1,326 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 29,603 | 6,623 | N/A | 46,960 | 4,189 |
| Other Financing Activity | -13 | -9 | -4 | -3,787 | -3,782 |
| Financing Cash Flow | $29,590 | $6,614 | $-4 | $43,173 | $407 |
| Beginning Cash Position | 14,555 | 14,555 | 14,555 | 38,829 | 38,829 |
| End Cash Position | 5,050 | 6,563 | 5,018 | 14,555 | 11,071 |
| Net Cash Flow | $-9,505 | $-7,992 | $-9,537 | $-24,274 | $-27,758 |
| Free Cash Flow | |||||
| Operating Cash Flow | -27,774 | -22,028 | -11,744 | -43,483 | -29,491 |
| Capital Expenditure | -294 | -250 | -218 | -130 | -105 |
| Free Cash Flow | -28,068 | -22,278 | -11,962 | -43,613 | -29,596 |